Acquisition of Freeline by Syncona becomes effective

Freeline Therapeutics and Syncona announced that, in connection with Syncona’s acquisition of Freeline by way of a scheme of arrangement, the Scheme has been sanctioned by the Court and the court order ,together with a copy of the scheme circular published by Freeline on January 18, 2024, has been delivered to the Registrar of Companies. Accordingly, the Scheme has become Effective in accordance with its terms and the entire issued share capital of Freeline is now owned or controlled by Syncona Portfolio Limited.